Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)

SHA:603669 Revenue

Lionco Pharmaceutical Group had revenue of 110.25M CNY in the quarter ending September 30, 2025, with 23.12% growth. This brings the company's revenue in the last twelve months to 430.61M, up 55.34% year-over-year. In the year 2024, Lionco Pharmaceutical Group had annual revenue of 379.78M with 92.95% growth.

• Revenue (ttm): 430.61M
• Revenue Growth: +55.34%
• P/S Ratio: 7.56
• Revenue / Employee: 987.64K
• Employees: 436
• Market Cap: 3.26B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	379.78M	182.95M	92.95%
Dec 31, 2023	196.83M	-92.43M	-31.95%
Dec 31, 2022	289.26M	-451.06M	-60.93%
Dec 31, 2021	740.33M	-260.67M	-26.04%
Dec 31, 2020	1.00B	-634.00M	-38.78%